The Subject Expert Committee on COVID-19 has given emergency use approval to Bharat Biotech’s Covaxin for children in the 2-18 years age group. The Hyderabad-based Vaccine manufacturer has completed Phase-2 and Phase-3 trials of Covaxin on children below 18 years of age in September.
The Trial data has been submitted to the Drugs and Comptroller General of India (DCGI) in the first week of October. And has got its emergency approval now. Previously, Zydus Cadila’s ZyCoV-D had received approved approval for all individuals aged 12 and above.
Covaxin, however, is the first vaccine for the 2-10 years group. It is not yet known when the vaccine will be administered and how. Also, we are yet to know if Government will administer the vaccine for children for free like how it is giving it for free for the 18+ age group.
Meanwhile, Covaxin is yet to get the emergency use authorization from the WHO. Only after that authorization, passengers with Covaxin can fly into other countries. Follow Mirchi9 on Google NewsThis Week Releases on OTT – Check ‘Rating’ Filter
Hiring Content Writer: We are looking to hire a ‘Telugu’ content writer. Send your sample articles to [email protected]Don't MissInside Story: Who Prepared Pawan Kalyan's Speech?We media usually address Pawan Kalyan as Powerstar while writing film news and as Janasena...Don't MissVenkatesh And Rana Together For Netflix Web SeriesThe dream of Daggubati fans has finally come true as Rana and Venkatesh Daggubati are...Don't MissLove Story All set For Record-Breaking Openings!Love Story starring Naga Chaitanya and Sai Pallavi is undoubtedly the biggest Telugu release post...Don't MissList Of New Titles Premiering On OTT This WeekHere is the list of new titles premiering on top OTT platforms like Netflix, Amazon...Don't MissThree Different Targets For Love Story TrioNaga Chaitanya and Sai Pallavi starrer Love Story is all set to hit the silver...